Name | Number of supported studies | Average coverage | |
---|---|---|---|
gamma-delta T cell | 3 studies | 22% ± 3% | |
glutamatergic neuron | 3 studies | 27% ± 8% |
Insufficient scRNA-seq data for expression of AKAP5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 95% | 1710.36 | 2510 / 2642 | 85% | 3.77 | 599 / 705 |
uterus | 98% | 294.65 | 166 / 170 | 74% | 2.33 | 338 / 459 |
lung | 99% | 293.35 | 570 / 578 | 68% | 1.72 | 788 / 1155 |
intestine | 96% | 287.37 | 927 / 966 | 71% | 2.28 | 373 / 527 |
kidney | 92% | 210.76 | 82 / 89 | 65% | 2.58 | 583 / 901 |
breast | 67% | 82.96 | 307 / 459 | 89% | 5.56 | 992 / 1118 |
bladder | 100% | 132.76 | 21 / 21 | 54% | 1.51 | 273 / 504 |
thymus | 89% | 126.95 | 581 / 653 | 57% | 1.00 | 342 / 605 |
prostate | 93% | 126.00 | 228 / 245 | 47% | 1.01 | 234 / 502 |
esophagus | 72% | 126.65 | 1036 / 1445 | 61% | 1.42 | 111 / 183 |
stomach | 50% | 54.20 | 178 / 359 | 70% | 2.04 | 200 / 286 |
spleen | 99% | 225.48 | 239 / 241 | 0% | 0 | 0 / 0 |
ovary | 68% | 80.59 | 122 / 180 | 30% | 0.51 | 129 / 430 |
blood vessel | 98% | 268.83 | 1302 / 1335 | 0% | 0 | 0 / 0 |
skin | 56% | 57.85 | 1017 / 1809 | 40% | 1.38 | 191 / 472 |
lymph node | 0% | 0 | 0 / 0 | 97% | 9.02 | 28 / 29 |
adrenal gland | 35% | 34.48 | 91 / 258 | 56% | 2.77 | 129 / 230 |
tonsil | 0% | 0 | 0 / 0 | 84% | 2.14 | 38 / 45 |
liver | 66% | 92.71 | 149 / 226 | 18% | 0.33 | 72 / 406 |
pancreas | 13% | 12.12 | 42 / 328 | 71% | 1.56 | 126 / 178 |
adipose | 70% | 80.67 | 846 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 56% | 256.92 | 516 / 929 | 0% | 0 | 0 / 0 |
heart | 16% | 14.35 | 134 / 861 | 0% | 0 | 0 / 0 |
muscle | 11% | 10.10 | 92 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.08 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007194 | Biological process | negative regulation of adenylate cyclase activity |
GO_0007165 | Biological process | signal transduction |
GO_0070886 | Biological process | positive regulation of calcineurin-NFAT signaling cascade |
GO_0033173 | Biological process | calcineurin-NFAT signaling cascade |
GO_0010738 | Biological process | regulation of protein kinase A signaling |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0007193 | Biological process | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_1900273 | Biological process | positive regulation of long-term synaptic potentiation |
GO_1905665 | Biological process | positive regulation of calcium ion import across plasma membrane |
GO_1905751 | Biological process | positive regulation of endosome to plasma membrane protein transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0043197 | Cellular component | dendritic spine |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0098837 | Cellular component | postsynaptic recycling endosome |
GO_0005829 | Cellular component | cytosol |
GO_0008287 | Cellular component | protein serine/threonine phosphatase complex |
GO_0014069 | Cellular component | postsynaptic density |
GO_0098944 | Cellular component | postsynaptic recycling endosome membrane |
GO_0060076 | Cellular component | excitatory synapse |
GO_0032590 | Cellular component | dendrite membrane |
GO_0034237 | Molecular function | protein kinase A regulatory subunit binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0050811 | Molecular function | GABA receptor binding |
GO_0097110 | Molecular function | scaffold protein binding |
GO_0031698 | Molecular function | beta-2 adrenergic receptor binding |
GO_0035254 | Molecular function | glutamate receptor binding |
GO_0008179 | Molecular function | adenylate cyclase binding |
GO_0005516 | Molecular function | calmodulin binding |
GO_0051018 | Molecular function | protein kinase A binding |
GO_0005515 | Molecular function | protein binding |
GO_0017124 | Molecular function | SH3 domain binding |
GO_0030346 | Molecular function | protein phosphatase 2B binding |
Gene name | AKAP5 |
Protein name | AKAP5 protein A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 79 kDa) (AKAP 79) (H21) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein) |
Synonyms | AKAP79 |
Description | FUNCTION: Multivalent scaffold protein that anchors the cAMP-dependent protein kinase/PKA to cytoskeletal and/or organelle-associated proteins, targeting the signal carried by cAMP to specific intracellular effectors . Association with the beta2-adrenergic receptor (beta2-AR) not only regulates beta2-AR signaling pathway, but also the activation by PKA by switching off the beta2-AR signaling cascade. Plays a role in long term synaptic potentiation by regulating protein trafficking from the dendritic recycling endosomes to the plasma membrane and controlling both structural and functional plasticity at excitatory synapses . . |
Accessions | Q6PG46 ENST00000320636.5 ENST00000394718.4 P24588 |